MicroMed Announces Closing of Reverse Merger and Financing

MicroMed Technology, Inc., a leader in miniaturized implantable ventricular assist technology, is pleased to announce that it has completed its previously announced merger with a wholly-owned subsidiary of Salmon Express, Inc. (OTCBB:SXPI.OB). The combined company has been renamed MicroMed Cardiovascular, Inc. and will have its shares publicly quoted on the OTC Bulletin Board. In connection with the merger, MicroMed also completed an equity financing through a private placement of $5 million of its common stock by Hunter World Markets, Inc. of Beverly Hills, California.

"The DeBakey VAD(R) is the result of years of dedication and perseverance to launch a generation of miniaturized technology designed to help thousands of victims of heart failure. The merger and concurrent financing will enable us to move forward as a public company, giving us greater access to the capital markets and more exposure for our DeBakey VAD technology," said Travis E. Baugh, President and CEO. "We believe that MicroMed is well positioned with a fully implantable VAD technology designed to support both adults and children with heart failure, a devastating and spiraling disease."